ICYMI: Eli Lilly's New Weight Loss Pill

<p>Shares in Eli Lilly surged on Friday &nbsp;after its experimental pill helped patients shed weight and control blood sugar about as well as Ozempic, an advance that could turbocharge what&rsquo;s already one of the fastest growing markets in medicine. Shares of the drug&rsquo;s originator Chugai Pharmaceutical Co. also soared.&nbsp;</p> <p><br />The triumph of Ozempic, the blockbuster diabetes shot from Novo Nordisk A/S, and related drugs including Zepbound and Mounjaro from Lilly, has set off an all-out push to develop a pill that&rsquo;s easier to take and less expensive to make. While rivals including Pfizer Inc. have suffered setbacks, analysts said success is critical to creating the $130 billion market they predict by the end of the decade.&nbsp;</p> <p>Hosts Carol Massar and Tim Stenovec speak with Bloomberg's Damian Garde about the new pill could mean for Eli Lilly.&nbsp;</p><p>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.</p>